Health insurance covers Exelon patch
Published: 2009-02-05 06:57:00
Updated: 2009-02-05 06:57:00
Novartis Korea said that Exelon Patch (rivastigmine transdermal patch), the first transdermal therapy for mild-to-moderate Alzheimer's disease, has been included in a list of insurance-covered medicines from February 2.
The one-daily Exelon Patch 5 and 10 are valued at 3,077 won and 3,100, res...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
